Sunil K. Ahuja, University of Texas Health Science Center, San Antonio, USA
Brigitte Autran, Hôpital La Pitié Salpetrière, Paris, France
Françoise Barré-Sinoussi, Institut Pasteur, Paris, France
Monsef Benkirane, IGH, Montpellier, France
Dennis R. Burton, The Scripps Research Institute, La Jolla, USA
Mary Carrington, NCI, Frederick, USA
Pierre Charneau, Institut Pasteur, Paris, France
Jean-François Delfraissy, ANRS, Paris, France
Ronald C. Desrosiers, Harvard Medical School, Southborough, USA
Daniel Douek, Vaccine Research Center, Bethesda, USA
Antony S. Fauci, NIAID, NIH, Bethesda, USA
Robert C. Gallo, Institute for Human Virology, Baltimore, USA
Ashley Haase, University of Minnesota, Minneapolis, USA

Peter Hale, Washington, USA
Thomas J. Hope, Northwestern University, Chicago, USA
Michel D. Kazatchkine, The Global Fund, Geneva, Switzerland
Richard A. Koup, Vaccine Research Center, Bethesda, USA
Peter D. Kwong, Vaccine Research Center, Bethesda, USA
Michael Malim, King's College, London, UK
Malegapuru W. Makgoba, University of KwaZulu-Natal, KwaZulu-Natal, South Africa
Andrew J. McMichael, Weatherall Institute of Molecular Medicine, Oxford, UK
Luc Montagnier, UNESCO, Paris, France
Gary Nabel, Vaccine Research Center, Bethesda, USA
Martine Peeters, IRD, Montpellier, France
Olivier Schwartz, Institut Pasteur, Paris, France
Wesley Sundquist, University of Utah, Salt Lake City, USA
Amalio Telenti, Institute for Microbiology, Lausanne, Switzerland
Alexandra Trkola, University Hospital Zurich, Switzerland
Simon Wain-Hobson, Institut Pasteur, Paris, France
Bruce D. Walker, Partners AIDS Research Center, Boston, USA
Robin A. Weiss, University College, London, UK